Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis.

Berta MoslehKarin SchelchThomas MohrThomas KlikovitsChristina WagnerLukas RatzingerYawen DongKatharina SinnAlexander RiesWalter BergerBettina Grasl-KrauppKonrad HoetzeneckerViktoria LaszloBalázs Dome Balazs HegedüsMarko JakopovicMir Alireza HodaMichael Grusch

Published in: Thoracic cancer (2023)

FGF18 is not a prognostic biomarker in PM. Its role in PM tumor biology and the clinical significance of decreased plasma FGF18 in PM patients warrant further investigation.

Keyphrases

particulate matter
air pollution
polycyclic aromatic hydrocarbons
end stage renal disease
heavy metals
ejection fraction
chronic kidney disease
prognostic factors
water soluble
patient reported outcomes